Cite
HARVARD Citation
Young, R. et al. (2018). Nab‐Paclitaxel plus gemcitabine in metastatic pancreatic adenocarcinoma: Australian subset analyses of the phase III MPACT trial. Asia-Pacific journal of clinical oncology. 14 (5), pp. e325-e331. [Online].